Ownership history in UBS Group AG · 28 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in CARDIFF ONCOLOGY INC (CRDF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 87,429 | -118,746 | -57.6% | 0.00% | $246K | $2.81 |
| 2025 Q3 | REDUCED | 206,175 | -426,825 | -67.4% | 0.00% | $425K | $2.06 |
| 2025 Q3 | ADDED | 633,000 | +435,562 | +220.6% | 0.00% | $1.3M | $2.06 |
| 2025 Q2 | REDUCED | 197,438 | -435,562 | -68.8% | 0.00% | $622K | $3.15 |
| 2025 Q2 | ADDED | 633,000 | +546,465 | +631.5% | 0.00% | $2.0M | $3.15 |
| 2025 Q1 | REDUCED | 86,535 | -546,465 | -86.3% | 0.00% | $272K | $3.14 |
| 2025 Q1 | ADDED | 633,000 | +603,000 | +2010.0% | 0.00% | $2.0M | $3.14 |
| 2024 Q4 | REDUCED | 30,000 | -603,000 | -95.3% | 0.00% | $130K | $4.34 |
| 2024 Q4 | ADDED | 633,000 | +349,648 | +123.4% | 0.00% | $2.7M | $4.34 |
| 2024 Q4 | ADDED | 283,352 | +234,788 | +483.5% | 0.00% | $1.2M | $4.34 |
As of 2025 Q4 — sorted by position size